These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33958004)

  • 1. Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?
    Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
    J Pharm Policy Pract; 2021 May; 14(1):42. PubMed ID: 33958004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis.
    Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
    Saudi Pharm J; 2020 May; 28(5):529-537. PubMed ID: 32435133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' views on cardiovascular disease risk prevention services by pharmacists and potential for collaboration.
    Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
    Explor Res Clin Soc Pharm; 2021 Dec; 4():100077. PubMed ID: 35479842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease.
    Puspitasari HP; Costa DSJ; Aslani P; Krass I
    Res Social Adm Pharm; 2016; 12(1):104-118. PubMed ID: 26001624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
    Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
    BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' experiences and views on providing screening services: An international comparison.
    Alzubaidi H; Namara KM; Saidawi W; Hasan S; Krass I
    Res Social Adm Pharm; 2020 Nov; 16(11):1558-1568. PubMed ID: 32830071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-Sectional Study on Pharmacy Students' Career Choices in the Light of Saudi Vision 2030: Will Community Pharmacy Continue to Be the Most Promising, but Least Preferred, Sector?
    Almaghaslah D; Alsayari A; Almanasef M; Asiri A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33926047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
    Fathima M; Saini B; Foster JM; Armour CL
    Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
    Karampatakis GD; Patel N; Stretch G; Ryan K
    BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Foundation Pharmacist Project: exploring new models of dual-sector postgraduate pharmacy training.
    Rathbone AP; Rokib T; Baqir W; Campbell D
    Int J Pharm Pract; 2019 Apr; 27(2):191-200. PubMed ID: 30088296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.